DDDD.L Share News (DDDD)
DDDD Share
DDDD Share
DDDD Share
DDDD Share
DDDD
DDDD Share
DDDD Broker
DDDD Directors
DDDD Financial
DDDD
DDDD Short
DDDDFri, 24th Jun 2022 12:35
(Sharecast News) - Biotherapeutics developer 4D Pharma requested an immediate suspension of trading in its shares on Friday.
The AIM-traded firm said it made the request pending a further announcement.
No further explanation was offered by the company.
"A further announcement will be made as soon as practicable," the board said in its short statement.
Reporting by Josh White at Sharecast.com.
Pharmaceutical company 4d Pharma has reported losses of £2.38m in its maiden set of full-year results. Basic losses per share totalled 4.81p. 4d, which uses selected bacteria to develop treatments, said that during the period its cash, cash equivalents, deposits and short-term investments increased
Read more